EquityBulls

Latest News

Diamond Power Infrastructure Ltd secures conductor supply order of Rs. 185 Crore from Adani Energy Solutions Ltd
GRE Renew Enertech Ltd receives orders worth Rs. 23.99 crores
Atishay Limited awarded order worth Rs. 49.35 lakhs
Ajmera Realty Q1 FY27 Operations: Sales Value Surges 35% to ₹146 Crore Powered by Strong Portfolio Realizations
CEAT Ltd - Q1 FY26-27 Consolidated Revenue Rs. 4,318 crore, up 22 % Y-o-Y

Keywords Selected: Capsules

Stock Report

Alembic Pharmaceuticals Ltd announces USFDA Tentative Approval for Larotrectinib Capsules, 25 mg and 100 mg
Alembic Pharmaceuticals Limited announces USFDA Final Approval for Fingolimod Capsules, 0.5 mg
Marksans Pharma Ltd receives USFDA approval for Benzonatate Capsules USP, 100 mg & 200 mg (Rx)
Zydus receives final approval from USFDA for Cevimeline Hydrochloride Capsules 30mg
Natural Biogenex and Fermbox Bio Enter Strategic Framework and Manufacturing Agreements to Strengthen Fermentation-Based CDMO Capabilities
Eugia Pharma announces launch of Pomalidomide Capsules in the US
NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst&®) in the U.S. market
Department of Drug Controller directs Natural Capsules Ltd to close operations of plant
Shelter Pharma Limited Launches D3 Cure Capsules
ZIM Laboratories Ltd receives approval from CDSCO - Directorate General of Health Services for Naproxen + Esomeprazole Capsules
Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval Dexlansoprazole Delayed Release Capsules, 30 mg and 60 mg
Zydus receives approval from China's NMPA for Venlafaxine Extended-Release Capsules, 75 mg and 150 mg
Zydus receives tentative approval from USFDA for Budesonide delayedrelease capsules, 4 mg
Lupin receives approval from U.S. FDA for Lenalidomide Capsules
Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
Zydus receives final approval from USFDA for Celecoxib Capsules, 50 mg, 100 mg, 200 mg and 400 mg
Aayush Wellness Ltd launches Brain Fuel Capsules
Zydus receives final approval from USFDA for Isotretinoin Capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg
Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
ZIM Laboratories Ltd receives Marketing Authorization for Dimethyl Fumarate (120 mg & 240 mg) Modified Release Capsules in Portugal, Europe
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mg
Alembic Pharmaceuticals announces USFDA Final Approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 120 mg, 180 mg, and 240 mg
Zydus receives final approval from USFDA for Enzalutamide Capsules, 40 mg